Search jobs Accelerating Innovation, Deepening Integration | Viva Biotech Online Investor Day Review SHANGHAI, Dec. 13, 2020 /PRNewswire/ -- Viva Biotech's Online Investor Day was successfully hosted on December 8, 2020. The management team conducted an online dialogue with nearly 400 investors, focusing on the company's strategy, personnel plans, technology platforms, integration strategic plans, investment incubation, and more. Dr. Chen Mao, Chairman and CEO of Viva Biotech, shared the market potential for CRO and CDMO companies, as well as the four major trends of the CXO industry. Dr. Mao also elaborated the innovative two-wheel driven business model of Viva Biotech that covers the CFS (Cash for Service) + EFS (Equity for Service). Along with the integration and expansion of the CFS business through the industrial chain and the continued growth of the EFS portfolio, Viva will continue adhering to their mission of "becoming a cradle for innovative biotech companies from around the world" while growing in sync with their achievements.